The largest database of trusted experimental protocols

Hiload superdex 75 column

Manufactured by GE Healthcare
Sourced in United States

The HiLoad Superdex 75 column is a size-exclusion chromatography column designed for the separation and purification of proteins, peptides, and other biomolecules. The column features a Superdex 75 resin, which provides efficient separation over a broad molecular weight range. This column is suitable for the purification of a variety of proteins and can be used in both analytical and preparative applications.

Automatically generated - may contain errors

15 protocols using hiload superdex 75 column

1

Structural Characterization of SLX4 BTB Domain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human SLX4BTB (residues 660–795) was expressed from a modified pET-28a vector that contained a SUMO protein fused after the N-terminal 6×His tag. Seleno-methionine labeling of the protein was achieved by expression in E. coli B834(DE3) supplemented with L-(+)-SelenoMethionine in the synthetic SelenoMethionine Expression Media (Molecular Dimensions). The protein was purified via Ni NTA affinity, followed by gel filtration chromatography on Hiload Superdex 75 column (GE Healthcare). Finally, the protein was concentrated to 35 mg/ml and stored in TN buffer (25 mM Tris-HCl pH8.0, 150 mM NaCl and 5 mM DTT).
Crystals of SLX4BTB were grown by sitting-drop vapor diffusion at 4°C under the condition of 27% PEG 400, 0.1 M HEPES pH7.5 and 300 mM CaCl2.
For detailed protein expression, purification, crystallization and structure determination, see Extended Experimental Procedures.
+ Open protocol
+ Expand
2

Purification and Characterization of Recombinant Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant BBK32-C proteins were expressed and purified as previously described (33 (link), 41 (link)). C1r-CCP2-SP, C1r-CCP2-SP zymogen mutants, and His-C1r-CCP2-SP were purified according to methods as described previously, with a final polishing step involving gel filtration chromatography on a HiLoad Superdex 75 column (GE Healthcare) (41 (link), 45 (link), 46 ). An autoproteolytic fragment of human C1r corresponding to residues 300–705 (UNIPROT: P00736) used in the crystallography experiment was obtained as previously described (41 (link)). Full length complement proteins C1r proenzyme, activated C1r, and C1s proenzyme were purchased from Complement Technology. In order to test for global changes in protein folding that may be induced by site-directed mutagenesis, recombinant proteins were evaluated for major changes in size by size exclusion chromatography (Fig. S3F). Proteins were separated on a HiLoad Superdex 200 Increase 10/300 column (GE Healthcare) and plotted against BioRad Standards to determine size. Monodisperse peaks for all BBK32-C related samples exhibited a ranging between 13.2 and 16.4 kDa.
+ Open protocol
+ Expand
3

Purification and Modification of RsrA Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
His-tagged RsrA was overproduced in E. coli BL21(λDE3)pLys harboring pET15b-RsrA, followed by purification with an Ni-NTA column as described previously (Kang et al., 1999 (link)). After removing the His-tag with thrombin, RsrA was purified by gel filtration chromatography on a HiLoad Superdex 75 column (GE Healthcare) in TN buffer (40 mM Tris-HCl at pH 7.5, 0.2 mM NaCl). Purified proteins were quantified using Pierce BCA Protein Assay Kit (Thermo Scientific). Reduced RsrA was prepared by incubating 200 nM RsrA in 10 mM DTT at 25°C for 1 h, with the subsequent addition of 400 nM ZnSO4 for 1 h in an anaerobic chamber (Coy) with 5% H2, 5% CO2, and 90% N2. Free zinc and DTT was removed by using a PD-10 desalting column and anaerobically prepared TN buffer. To analyze para-benzoquinone (BQ)-modified RsrA, 100 nM reduced RsrA in 300 μL buffer was treated with 50 μM BQ for 10 or 20 min, and electrophoresed on SDS-PAGE followed by silver staining. For mass analysis, 50 μM reduced RsrA in 300 μL buffer was treated with 1 mM BQ for 20 min, followed by denaturation in 8 M urea.
+ Open protocol
+ Expand
4

Recombinant OXA-48 Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recombinant pET26b-OXA-48 plasmid was transformed into E. coli BL21(DE3). The OXA-48 protein was cultured in LB media with kanamycin (100 mg/L) for 3–4 h at 37°C and IPTG was added to induce expression at 20°C overnight. The cells were collected by centrifugation (14,000×g, 4°C, 30 min) and then sonicated. The lysate was loaded on a HiTrap SP HP column equilibrated with 20 mM HEPES (pH 7.0). The target protein was eluted with buffer containing NaCl at a concentration of 200 mM, and then concentrated by using an Amicon centrifugal filter. A size-exclusion chromatography using a HiLoad Superdex 75 column (GE Healthcare) was performed to further purify OXA-48 with a running buffer consisting of 20 mM HEPES (pH 7.0) supplemented with 200 mM NaCl. The concentration of purified OXA-48 was determined by UV spectrophotometry according to Lambert–Beer’s Law with an extinction coefficient of 65,430 M−1 cm−1 at 280 nm.
+ Open protocol
+ Expand
5

Purification and Characterization of eRF1 and RT Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length mouse eRF1 (sharing 100% sequence identity with human eRF1) and its N-, M- and C-domains, as well as MoMLV RT lacking its N-terminal region (aa 24–671), an isolated RT polymerase domain (aa 24–499) and an isolated RT RNase H domain (aa 500–671) were cloned into the vector pGEX-6P-1 (GE Healthcare) and expressed as GST fusion proteins in E. coli BL21-CodonPlus(DE3)-RIL strain (Agilent Technologies). The mutants were created using QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies). WT and mutant proteins were purified by Glutathione Sepharose 4B resin, followed by PreScission protease cleavage, ion exchange and gel filtration chromatography (GE Healthcare). To make the RT/eRF1 complex, equal molarity of RT and eRF1 were mixed in gel filtration buffer (20 mM HEPES pH 7.5, 150 mM NaCl and 2 mM DTT) and loaded into the Hiload Superdex 200 column (GE Healthcare). The fractions containing the complex were pooled and concentrated to around 10 mg ml−1. The RNase H/eRF1-C complex was similarly prepared but purified instead using the Hiload superdex 75 column (GE healthcare) equilibrated with gel filtration buffer (20 mM HEPES pH 7.5, 150 mM NaCl and 5 mM DTT) and concentrated to 65 mg ml−1.
+ Open protocol
+ Expand
6

Chicken Adiponectin Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For chicken Adiponectin purification, the egg-white was added to same volume of 40% ammonium sulfate. The mixture was stirred for overnight at 4°C, and then centrifuged for 1 h at 4°C at 3000 g. The pellet was resuspended in four volumes of 20 mM Tris-HCl, 50 mM NaCl buffer (pH 8.0) to original egg-white volume. Then, the sample was filtered through a 0.22 μm bottle filter. The sample was loaded onto a 5 ml HiTrap Q column (GE Healthcare Bio-Sciences, Uppsala, Sweden), and the protein was eluted with 100 ml gradient 20 mM Tris-HCl, 1 M NaCl buffer (pH 8.0). The protein was further purified and fractionated by size-exclusion chromatography (SEC) using a HiLoad Superdex 75 Column (GE Healthcare Bio-Sciences) pre-equilibrated with 20 mM Tris-HCl, 50 mM NaCl buffer (pH 8.0).
+ Open protocol
+ Expand
7

Fluorescent Ubiquitin and Thioester Conjugate

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescently tagged ubiquitin was produced by introducing a Cys residue before the beginning of the ubiquitin sequence, resulting in Met-Cys-ubiquitin. To label the free Cys purified ubiquitin was reduced with 1 mM TCEP and mixed with 5 µL of Cy3 for 1 h. The sample was desalted (5 mL HiTrap desalting, GE) to remove excess dye and incubated in the dark at room temperature for ~16 h to allow unconjugated ubiquitin to form disulphide-linked dimers. Subsequently, the mixture was separated on a 16/600 HiLoad Superdex 75 column (GE) and the second peak corresponding to monomeric ubiquitin was pooled and concentrated to ~2 mg mL−1. Thioester-linked conjugate containing fluorescent ubiquitin was produced and purified using similar conditions as before,50 (link) except Ubc13 with a K97R mutation was mixed with ubiquitin, E1 and ATP cycling buffer at pH 7.5. The thioester charging reaction was incubated at 37 °C for 20 min before the conjugate was purified using a 10/300 Superdex 75 column (GE) equilibrated with 20 mM MES pH 6.5, 150 mM NaCl. The fractions containing conjugate were immediately flash frozen in liquid nitrogen.
+ Open protocol
+ Expand
8

Purification of Ubiquitin and Pol ι

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ubiquitin and the catalytic domain of Pol ι were expressed and purified in a similar manner. Briefly, plasmids encoding His Pol ι aa 1–419 and full-length ubiquitin were transformed into E. coli BL21(DE3) cells. Unlabeled proteins used for NMR experiments were expressed in 1 L of Luria broth (LB) media. The 15N-labeled sample of Pol ι was obtained by expressing proteins in M9 minimal medium supplemented with 15N-ammonium chloride as a sole source of nitrogen. Transformed cells were grown at 37 °C until OD600 of 0.8–1.0. Protein expression was induced with 1 mM isopropyl 1-thio-β-ᴅ-galactopyranoside (IPTG) overnight at 20 °C. Cells were harvested by centrifugation, resuspended in a buffer containing 20 mM Tris pH 8.0, 200 mM NaCl, 10 mM imidazole and 1 mM PMSF, lysed by sonication, and centrifuged at 15,000 rpm for 30 min. The supernatant was filtered and applied to equilibrated HisPur Cobalt resin (Thermo Scientific). Proteins were eluted in a buffer containing 20 mM Tris pH 8.0, 200 mM NaCl and 250 mM imidazole and then subjected to size-exclusion chromatography using a HiLoad Superdex 75 column (GE Healthcare) in a buffer containing 20 mM Tris pH 6.5, 100 mM NaCl and 10 mM β-mercaptoethanol.
+ Open protocol
+ Expand
9

Fluorescence Polarization Assay for 14-3-3 Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both S. cerevisiae 14–3–3 isoforms (Bmh1 and Bmh2) were expressed and purified as described previously [47] (link), [48] (link). The N-terminal 6 ×His-tag was removed using TEV protease, and final size-exclusion chromatography was performed in a HiLoad Superdex 75 column (GE Healthcare, Chicago, IL, USA). Bmh1 and Bmh2 were dialyzed overnight into a buffer containing 10 mM HEPES (pH 7.4) and 150 mM NaCl. Proteins at an initial concentration of 160 μM, followed by binary dilution series, were incubated for 1 h with 50 nM of FITC-labeled synthetic Trk1 peptide (FITC-RRCFpTLLFP), where pT denotes phosphothreonine (Pepscan Presto BV, Lelystad, Netherlands). The dilution series were performed in 384-well black low-volume flat-bottom plates (Corning, NY, USA) in a buffer containing 10 mM HEPES (pH 7.4), 150 mM NaCl, 0.1% (v/v) Tween 20% and 0.1% (w/v) BSA, using an epMotion P5073 pipetting robot (Eppendorf, Hamburg, Germany). Fluorescence polarization assay was measured using a CLARIOstar microplate reader (BMG Labtech, Thermo Fisher Scientific, Waltham, MA, USA) at 23 °C. The excitation and emission wavelengths were 482 nm and 530 nm, respectively. The KD values were determined as the mean of four independent measurements.
+ Open protocol
+ Expand
10

Purification of CWC22, CWC27, and EIF4A3 Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For X-ray structure, recombinant proteins CWC22 and CWC27 were co-expressed in E. coli BL21 (DE3) grown in TB-medium at 37°C, as GST-3C-N-terminal His6 fusion or Sumo cleavable N-terminal His6 fusion proteins respectively. EIF4A3 was expressed as a Sumo cleavable N-terminal His6 fusion. Overexpression was induced at 18°C with 0.5 mM IPTG. Cells were lysed by sonication in 50 mM Na2HPO4 pH 7.5, 250 mM NaCl, 10 mM imidazole, 1 mM PMSF, and 25 mg/ml DNaseI, and the extract was cleared by centrifugation (4°C, 75 000 g, 30 min). In a first step, proteins were purified via a Ni2+-NTA affinity column (5 ml, GE healthcare). In order to remove N-terminal His6-tags, proteins were incubated with 3C or Senp2 proteases overnight at 4°C and dialyzed against 50 mM Na2HPO4 pH 7.5, 150 mM NaCl for subsequent heparin chromatography (5 ml Heparin Q sepharose, GE Healthcare). Protein complexes were isolated by size exclusion chromatography (SEC) after concentrating to 20–30 mg/ml in a buffer containing 10 mM HEPES pH 7.5, 150 mM NaCl and 1 mM DTT using a HiLoad Superdex 75 column (GE Healthcare). The complex was stored at 80°C in SEC buffer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!